Navigation Links
A Drug That Carries a Lower Risk of Weight Gain Than AstraZeneca's Seroquel and Has Antimanic and Antidepressant Effects Would Earn a 30 Percent Patient Share in Bipolar Disorder Treatment
Date:4/22/2008

Seroquel's Successor, Seroquel XR, Will Earn a 16 Percent Patient Share in

the Bipolar Disorder Market by 2016, According to a New Report from

Decision Resources

WALTHAM, Mass., April 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a therapy that carries a lower risk of weight gain than AstraZeneca's Seroquel and has both antimanic and antidepressant effects would earn a 30 percent patient share in the treatment of bipolar disorder, according to surveyed psychiatrists.

The new report entitled Bipolar Disorder: Although Bipolar Mania Is a Crowded Market, Physicians Continue to Demand Better Treatment finds that surveyed psychiatrists indicate that they would prescribe AstraZeneca's Seroquel XR to 20 percent of their bipolar disorder patients, following its approval for the indication in 2009. As a result, Seroquel XR is forecasted to earn a 16 percent patient share in the U.S. bipolar disorder market in 2016.

The report also finds that Seroquel XR will earn gold-standard status for treatment of bipolar disorder in 2011 as interviewed psychiatrists indicate that Seroquel XR's delivery profile -- once-daily dosing -- will be marginally superior to that of Seroquel immediate-release. Although surveyed psychiatrists indicated that lithium and Eli Lilly's Zyprexa have advantages in efficacy, lithium and Zyprexa have disadvantages in safety, tolerability and/or delivery when compared to Seroquel.

"Interviewed psychiatrists report that Seroquel can sometimes require twice-daily dosing for sustained efficacy," said Kate Hohenberg, director at Decision Resources. "As a result, Seroquel XR narrowly edges out its parent compound to become the new gold standard because of its incremental advantage in delivery."

About the Report

Bipolar Disorder: Although Bipolar Mania Is a Crowded Market, Phy
'/>"/>

SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Obesity During Pregnancy Carries Bigger Price Tag
2. Survival rates appear lower for scalp and neck melanoma than for other sites
3. Hospital Care in Singapore Now Available to American Patients at Pre-Negotiated, In-Network Rates Far Lower than Comparable Services in the U.S.
4. Bioponic Phytoceuticals Announces Curecumin(TM) May Lower Heart Failure Risk
5. AUDIO from Medialink and Apple Products Research and Education Council: New Research -- Adults Who Eat Apples, Apple Juice Have Healthier Diets and Lower Risk for Metabolic Syndrome
6. Risk of Womens Heart Attack or Stroke Appears to Be Lowered by DASH Diet
7. Blocking the effect of inflammation-causing cells lowered prostate cancer cells invasion
8. Adults who eat apples, drink apple juice have lower risk for metabolic syndrome
9. Medco Acquires Majority Interest in Europa Apotheek; Delivering Innovation, Clinical Quality and Lower-Cost Solutions to Fast-Growing German Health Care Market
10. Lowering Blood Pressure Improves Brain Hemorrhage Outcomes
11. Significant reductions in mortality shown using blood pressure-lowering treatment in very elderly

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Rabbits implanted with new cells regained sexual...v. 9 (HealthDay News) -- Researchers were able to ...nises by growing new penile tissue in the lab and ...human application is a ways off, researchers say t... erectile dysfunction in men. , "We were able t...
(Date:11/9/2009)... , Tomorrow may be too la...etes condition, according to TOPS Club, Inc. (Take...upport organization. , (V... when it comes to preventing or improving a diabet...ff Pounds Sensibly), the nonprofit weight-loss sup...
(Date:11/9/2009)... , SANTA MONICA, Calif., Nov. 9 /PRNewswire/ ... Foundation joined philosophy on Saturday to...nce support services throughout California by buil... shelters. Enough kits were created to give one t...served in one of Los Angeles County,s domestic vio...
(Date:11/9/2009)... , DETROIT, Nov. 9 ...armanos Cancer Center has been selected the most p...higan, according to a survey by the National Resea...m.com/cgi-bin/prnh/20071106/KARMANOSLOGO ) ,, ...uestionnaire between September 2008 and August 200...
(Date:11/9/2009)... , NEW YORK, Nov. 9 /PRNewswire/ -- Phoen...l and drug abuse treatment and prevention program,...h.D., a nationally and internationally recognized ...as Chief Clinical Officer, effective January 1, 20...ont of substance abuse treatment research and her ...
Breaking Medicine News(10 mins):Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3
...ients with clinically operable cervical cancer fro...retreatment imaging does not lead to increased sur...developed a decision-analytic model to determine t... Boston, and lead author of the study. What we fou...
... Stem Cell Network Annual Science Meeting in Edinb...isms normally involved in balancing different func... Her team from Barts and the London School of Med...gnant brain tumours. This work has been funded by...
...ood cell production is controlled could lead to im...anaemia, according to West Australian medical rese...s published in Blood, the journal of the American ...Research (WAIMR) Director Peter Klinken and his La...
...ry on how immune system responds to invaders , ...e system T-cells don,t begin to multiply until up ...ng that changes current thinking about how the imm...an evolutionary safeguard against the risk of an a...
...centric Medical,Inc., the global leader in devices...ay announced that Maria Sainz has been named Presi...he new appointment was effective,April 8, 2008., ... Cardiac Surgery division of Guidant Corporation a...
...ify Systems, Inc., a,real-time compression technol...amplify for Windows Release 2.6 and Samplify for W...vides the same compression and,decompression engin..., "Many of our customers in the defense and medic...
Other Medicine News:Health News:Stem cells and cancer: Scientists investigate a fine balancing act 2Health News:Twin findings raise hopes of improved anemia treatments 2Health News:T-Cell Duplication Delayed Up to 3 Days After Infection 2Health News:Maria Sainz Named President and CEO of Concentric Medical 2Health News:Samplify Systems Announces Availability of Samplify for Windows Release 2.6, and Samplify for Windows Embedded Edition, Transforming RF Data Recording Applications with X-COM Systems 2Health News:Samplify Systems Announces Availability of Samplify for Windows Release 2.6, and Samplify for Windows Embedded Edition, Transforming RF Data Recording Applications with X-COM Systems 3
(Date:11/9/2009)...D LASERS just announced that industry leading dent... position of Medical Director. In his new role, D...ch and development of new soft and hard tissue den...g education credits, authoring articles for relate...ng and seminar engagements. ,, "We are very for...
(Date:11/9/2009)...swire/ -- Unwavering from its pursuit of producing...,s economic climate, Lutronic, Inc., a leading dev...troduces the MOSAIC CO2, a full-featured fractiona...OSAIC CO2 offers many of the features unique to Lu...and stamping operation modes and patented Controll...
(Date:11/9/2009)...all/ -- Arcadia Resources, Inc. (NYSE Amex: KAD )... care services under the Arcadia HealthCare(SM) br...of Directors. Goldsmith will replace Tres Lund wh..., (Photo: http://www.newscom.com/cgi-bin/prnh/2...Paul Professor of Government and Director of Innov...
Breaking Medicine Technology:AMD LASERS Names Dr. James Jesse as Medical Director 2Lutronic(R) Unleashes the New MOSAIC CO2 2Arcadia Resources Names Stephen Goldsmith to Board of Directors 2Arcadia Resources Names Stephen Goldsmith to Board of Directors 3PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 1PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 2PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 3PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 4PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 5PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 6Lithium Ion Battery Maker Names New President 13967 1Lithium Ion Battery Maker Names New President 13967 2Lithium Ion Battery Maker Names New President 13967 3Lithium Ion Battery Maker Names New President 13967 4Lithium Ion Battery Maker Names New President 13967 5Lithium Ion Battery Maker Names New President 13967 6Pandemic flu can infect cells deep in the lungs says new research 9859 1Pandemic flu can infect cells deep in the lungs says new research 9859 2Pandemic flu can infect cells deep in the lungs says new research 9859 3
...etion of Phase III Trials of Light Infusion Therap...ectal Cancer and Phase I/II and Phase II... Wash., July 15 Light Sciences Oncology, Inc.,(LS...sion Therapy(TM),(Litx(TM)) to treat cancer and ot... $40.1 million in a Series C round of financing. T...
...is of the Alzheimer,s Disease Market Now Available...WALTHAM, Mass., July 15 Decision Resources, one o...for pharmaceutical and,healthcare issues, finds th...continue the development of Flurizan, the most lik...disease treatment becomes Elan/Wyeth,s,bapineuzuma...
Other Medicine Technology:Light Sciences Oncology Raises $40.1 Million in Series C Financing 2Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimer's Drug After Flurizan's Discontinuation 2
...program offers state-of-the-art quality in an inst... strength and durability. Low profile cutting tips...Series I instruments are available in just about e...r large and small joint arthroscopic procedures.,...
...program offers state-of-the-art quality in an inst... strength and durability. Low profile cutting tips...Series I instruments are available in just about e...r large and small joint arthroscopic procedures.,...
...es facilitates fast and effective resection of men...y shaped meniscal rim. The flat, crescent-shaped t... tightest joint spaces. Made in the U.S. at Arthre...ence in arthroscopy hand instrument design guarant...
...es facilitates fast and effective resection of men...y shaped meniscal rim. The flat, crescent-shaped t... tightest joint spaces. Made in the U.S. at Arthre...ence in arthroscopy hand instrument design guarant...
Medicine Products: